| scholarly article | Q13442814 |
| P50 | author | Richard L Gieseck | Q59702652 |
| P2093 | author name string | Thomas A Wynn | |
| Allen W Cheever | |||
| Margaret M Mentink-Kane | |||
| Thirumalai R Ramalingam | |||
| Kevin M Hart | |||
| Kevin M Vannella | |||
| Thomas H Acciani | |||
| P2860 | cites work | Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription | Q24311810 |
| TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses | Q28115227 | ||
| Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
| Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis | Q28281586 | ||
| Interleukin-13: central mediator of allergic asthma | Q28291712 | ||
| Modulation of murine macrophage function by IL-13 | Q28505558 | ||
| Mechanisms of fibrosis: therapeutic translation for fibrotic disease | Q29620307 | ||
| Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies | Q30957004 | ||
| Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. | Q33799732 | ||
| An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response | Q33853821 | ||
| Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. | Q33904042 | ||
| Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection | Q34146893 | ||
| Lebrikizumab treatment in adults with asthma | Q34205683 | ||
| Regulatory T cells in the control of immune pathology. | Q34348983 | ||
| Role of interleukin-13 in fibrosis, particularly systemic sclerosis | Q34360300 | ||
| Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression | Q34371002 | ||
| Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. | Q34390186 | ||
| Acquisition of lymphokine-producing phenotype by CD4+ T cells | Q34724514 | ||
| Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage | Q35114200 | ||
| Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis | Q35219977 | ||
| Fibrotic disease and the T(H)1/T(H)2 paradigm | Q35852270 | ||
| Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis | Q36225950 | ||
| Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni | Q36229789 | ||
| Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology | Q36363125 | ||
| Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response | Q36370595 | ||
| Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses | Q36591648 | ||
| Functional diversity of T lymphocytes due to secretion of different cytokine patterns | Q37079865 | ||
| Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. | Q37213084 | ||
| MicroRNA-mediated regulation of T helper cell differentiation and plasticity. | Q37693699 | ||
| TNFα in myocardial ischemia/reperfusion, remodeling and heart failure | Q37767172 | ||
| Asthma phenotypes: the evolution from clinical to molecular approaches | Q38007831 | ||
| Th2 responses in schistosomiasis. | Q38058759 | ||
| Innate lymphoid cells--how did we miss them? | Q38071916 | ||
| Protective and pathological roles of mast cells and basophils | Q38096294 | ||
| TH2, allergy and group 2 innate lymphoid cells | Q38107790 | ||
| Type 2 cytokines: mechanisms and therapeutic strategies | Q38424752 | ||
| Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender | Q38882456 | ||
| TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. | Q41042964 | ||
| Allergic host defences | Q41190858 | ||
| Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses | Q42944667 | ||
| IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent | Q44007756 | ||
| Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent | Q44826352 | ||
| Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts | Q46373486 | ||
| A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis | Q48033849 | ||
| Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis. | Q49163938 | ||
| Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. | Q52543547 | ||
| High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni | Q58312856 | ||
| An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection | Q59054213 | ||
| Cytokine Regulation of Periportal Fibrosis in Humans Infected with Schistosoma mansoni: IFN- Is Associated with Protection Against Fibrosis and TNF- with Aggravation of Disease | Q63409796 | ||
| Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators | Q73336547 | ||
| Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors | Q73348784 | ||
| Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts | Q73478890 | ||
| IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis | Q73869153 | ||
| Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases | Q77337921 | ||
| IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs | Q77899629 | ||
| Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile | Q77929251 | ||
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 344-354 | |
| P577 | publication date | 2016-06-10 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ | |
| P478 | volume | 239 |
| Q92715660 | A single nucleotide polymorphism of the interferon-γ gene and susceptibility to hepatitis B virus-related cirrhosis: a randomized controlled trial |
| Q97646409 | Attenuation of Dupuytren's fibrosis via targeting of the STAT1 modulated IL-13Rα1 response |
| Q58746538 | Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis |
| Q102389095 | Fibrosis: from mechanisms to medicines |
| Q88089775 | Macrophages, Wound Healing, and Fibrosis: Recent Insights |
| Q88899477 | Mechanisms of Normal Tissue Injury From Irradiation |
| Q49959033 | Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice. |
| Q50108035 | Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review. |
| Q45058787 | Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. |
| Q33904342 | The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis |
| Q41273741 | The Role of Cytokines in the Fibrotic Responses in Crohn's Disease |
| Q39443675 | The peritoneum: healing, immunity, and diseases |
| Q57110142 | Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis |
| Q40074887 | Type 2 immunity in tissue repair and fibrosis |
Search more.